摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3'-carboxamido-4-nitro-biphenyl | 188665-78-3

中文名称
——
中文别名
——
英文名称
3'-carboxamido-4-nitro-biphenyl
英文别名
4'-nitrobiphenyl-3-carboxamide;3-(4-Nitrophenyl)benzamide
3'-carboxamido-4-nitro-biphenyl化学式
CAS
188665-78-3
化学式
C13H10N2O3
mdl
——
分子量
242.234
InChiKey
MBPCOTANORRIPC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    453.5±28.0 °C(Predicted)
  • 密度:
    1.307±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    88.9
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3'-carboxamido-4-nitro-biphenyl吡啶 、 palladium 10% on activated carbon 、 氢气 作用下, 以 甲醇 为溶剂, 反应 15.0h, 生成 4'-(6-methoxynaphthalene-2-sulfonamido)biphenyl-3-carboxamide
    参考文献:
    名称:
    Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA)
    摘要:
    Recent drug discovery programs targeting urokinase plasminogen activator (uPA) have resulted in non-peptidic inhibitors consisting of amidine or guanidine functional groups attached to aromatic or heteroaromatic scaffolds. There is a general problem of poor oral bioavailability of these charged inhibitors. In this paper, we report the synthesis and evaluation of a series of naphthamide and naphthalene sulfonamides as uPA inhibitors containing non-basic groups as substitute for amidine or guanidine groups. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.12.040
  • 作为产物:
    描述:
    4-硝基联苯-3-羧酸氯化亚砜 作用下, 以 甲醇甲苯 为溶剂, 反应 24.0h, 生成 3'-carboxamido-4-nitro-biphenyl
    参考文献:
    名称:
    Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA)
    摘要:
    Recent drug discovery programs targeting urokinase plasminogen activator (uPA) have resulted in non-peptidic inhibitors consisting of amidine or guanidine functional groups attached to aromatic or heteroaromatic scaffolds. There is a general problem of poor oral bioavailability of these charged inhibitors. In this paper, we report the synthesis and evaluation of a series of naphthamide and naphthalene sulfonamides as uPA inhibitors containing non-basic groups as substitute for amidine or guanidine groups. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.12.040
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS FOR TREATING TUBERCULOSIS<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DE LA TUBERCULOSE
    申请人:UNIV NANYANG TECH
    公开号:WO2018151681A1
    公开(公告)日:2018-08-23
    The present invention relates to pyrimidine compounds and compositions for treating tuberculosis. These compounds may be used to target the F1 domain of F-ATP synthase and may be used with bedaquiline or 6-chloro-2-ethyl-N-[[4-[4- [4-(trifluoromethoxy)phenyl]piperidin-1 -yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide (Q203) or a combination thereof.
    本发明涉及嘧啶化合物和用于治疗结核病的组合物。这些化合物可用于靶向F-ATP合成酶的F1结构域,并可与贝达昆林或6-氯-2-乙基-N-[[4-[4- [4-(三氟甲氧基)苯基]哌啶-1-基]苯基]甲基]咪唑[1,2-a]吡啶-3-羧酰胺(Q203)或二者的组合物一起使用。
  • Biaryl derived amide modulators of vanilloid VR1 receptor
    申请人:Codd Ellen
    公开号:US20060223837A1
    公开(公告)日:2006-10-05
    The invention is directed to novel vanilloid receptor type 1 (VR1) ligands. More specifically, the invention relates to novel biaryl-derived amides that are potent antagonists or agonists of VR1. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
    该发明涉及新型辣椒素受体类型1(VR1)配体。更具体地,该发明涉及新型联苯基衍生酰胺,这些酰胺是VR1的有效拮抗剂或激动剂。还描述了利用该发明化合物治疗轻度至严重疼痛和各种疾病的药物和兽医组合物以及治疗方法。
  • [EN] HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1<br/>[FR] AMIDES HÉTÉROCYCLIQUES EN TANT QUE MODULATEURS DE LA TRPA1
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2010141805A1
    公开(公告)日:2010-12-09
    Certain heterocyclic amide compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPA1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease.
    描述了某些杂环酰胺化合物。这些化合物可用于制备药物组合物,以及用于治疗由TRPA1活性介导的疾病状态、紊乱和条件,如疼痛、关节炎、瘙痒、咳嗽、哮喘或炎症性肠病的方法。
  • A new approach to the solid-phase Suzuki coupling reaction
    作者:Serge R. Piettre、Sylvie Baltzer
    DOI:10.1016/s0040-4039(97)00063-4
    日期:1997.2
    Treatment of polymer-bound aryl halides with pinacol ester of diboron under palladium (0) catalysis gave the corresponding polymer-bound boronates. The Suzuki coupling reaction was then carried out using a variety of aryl halides. Cleavage from the solid support delivered the expected products in usually good yields and high purity.
    在钯(0)催化下,用乙硼酸频哪醇酯处理与聚合物结合的芳基卤化物,得到相应的与聚合物结合的硼酸酯。然后使用多种芳基卤化物进行Suzuki偶联反应。从固相支持物上的裂解通常以良好的收率和高纯度提供了预期的产物。
  • Aryldiazonium Tetrafluoroborate Salts as Green and Efficient Coupling Partners for the Suzuki–Miyaura Reaction: From Optimisation to Mole Scale
    作者:Aymeric P. Colleville、Richard A. J. Horan、Nicholas C. O. Tomkinson
    DOI:10.1021/op5002353
    日期:2014.9.19
    The use of aryldiazonium tetrafluoroborate salts as coupling partners in the Suzuki-Miyaura reaction was investigated from a process chemistry perspective including safety evaluation, solvent and catalyst screening and multivariate factor optimisation. Optimised conditions were applied to a range of substrates to evaluate the scope and limitations of the reaction, and one example was carried out on mole scale to demonstrate the practicality and scalability of the process.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐